Trials / Completed
CompletedNCT03899922
Monitoring Drug-induced Uveitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (actual)
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Several drugs and chemotherapies seem to induce uveitis. This study investigates reports of uveitis, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).
Detailed description
Several drugs and chemotherapies seem to have an impact on the eyes and are responsible of uveitis. Those are poorly described, due to the modification of the pharmacopeia, and the recent recognition of several of these adverse events. This study investigates the main characteristics of patients affected by uveitis side effect imputed to drugs. A causality assessment according to the WHO-UMC (World Health Organization - Uppsala Monitoring Center) is systematically applied.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Drugs inducing uveitis | Drugs susceptible to induce uveitis |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2020-04-01
- Completion
- 2023-04-04
- First posted
- 2019-04-02
- Last updated
- 2023-04-05
Locations
1 site across 1 country: France
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03899922. Inclusion in this directory is not an endorsement.